Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
Damiani D, Tiribelli M, Geromin A, Cerno M, Sperotto A, Toffoletti E, Simeone E, Michelutti A, Cavallin M, Fanin R. Damiani D, et al. Among authors: toffoletti e. Ann Hematol. 2012 Dec;91(12):1937-43. doi: 10.1007/s00277-012-1551-x. Epub 2012 Aug 15. Ann Hematol. 2012. PMID: 22893485
Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy.
Tiribelli M, Colatutto A, Marin L, Barbina G, Qualizza U, Damiani D, Toffoletti E, Medeot M, Candoni A, Tonutti E, Sala P, Fanin R. Tiribelli M, et al. Among authors: toffoletti e. Am J Hematol. 2008 Jun;83(6):517-8. doi: 10.1002/ajh.21157. Am J Hematol. 2008. PMID: 18306359 Free article. No abstract available.
Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.
Candoni A, Martinelli G, Toffoletti E, Chiarvesio A, Tiribelli M, Malagola M, Piccaluga PP, Michelutti A, Simeone E, Damiani D, Russo D, Fanin R. Candoni A, et al. Among authors: toffoletti e. Leuk Res. 2008 Dec;32(12):1800-8. doi: 10.1016/j.leukres.2008.05.011. Epub 2008 Jul 14. Leuk Res. 2008. PMID: 18621416 Clinical Trial.
Quantitative assessment of WT1 gene expression after allogeneic stem cell transplantation is a useful tool for monitoring minimal residual disease in acute myeloid leukemia.
Candoni A, Tiribelli M, Toffoletti E, Cilloni D, Chiarvesio A, Michelutti A, Simeone E, Pipan C, Saglio G, Fanin R. Candoni A, et al. Among authors: toffoletti e. Eur J Haematol. 2009 Jan;82(1):61-8. doi: 10.1111/j.1600-0609.2008.01158.x. Epub 2008 Sep 17. Eur J Haematol. 2009. PMID: 18801058
Prognostic factors and outcome of Epstein-Barr virus DNAemia in high-risk recipients of allogeneic stem cell transplantation treated with preemptive rituximab.
Patriarca F, Medeot M, Isola M, Battista ML, Sperotto A, Pipan C, Toffoletti E, Dozzo M, Michelutti A, Gregoraci G, Geromin A, Cerno M, Savignano C, Rinaldi C, Barbone F, Fanin R. Patriarca F, et al. Among authors: toffoletti e. Transpl Infect Dis. 2013 Jun;15(3):259-67. doi: 10.1111/tid.12061. Epub 2013 Feb 13. Transpl Infect Dis. 2013. PMID: 23405972
The hidden genomic landscape of acute myeloid leukemia: subclonal structure revealed by undetected mutations.
Bodini M, Ronchini C, Giacò L, Russo A, Melloni GE, Luzi L, Sardella D, Volorio S, Hasan SK, Ottone T, Lavorgna S, Lo-Coco F, Candoni A, Fanin R, Toffoletti E, Iacobucci I, Martinelli G, Cignetti A, Tarella C, Bernard L, Pelicci PG, Riva L. Bodini M, et al. Among authors: toffoletti e. Blood. 2015 Jan 22;125(4):600-5. doi: 10.1182/blood-2014-05-576157. Epub 2014 Dec 12. Blood. 2015. PMID: 25499761 Free PMC article. Review.
25 results